Danielle Ellis

Danielle Ellis

Editor-in-Chief

Biological Sciences, B.Sc.

Danielle graduated with a 2:1 in Biological Sciences with a Professional Training Year from Cardiff University. During her Professional Training Year, Danielle worked with the registered charity the Frozen Ark Project, creating and promoting various forms of content within their brand guidelines.

See more

Since joining AZoNetwork and becoming an editor on News-Medical, Danielle has completed an HMX Fundamentals Program from Harvard Medical School and earned a Certificate of Completion in Immunology.

Danielle has a great appreciation and passion for science communication and enjoys reading non-fiction and fiction in her spare time. Her other interests include doing yoga, collecting vinyl, and visiting museums.

See less

Articles from Danielle

International Women's Day 2022: Breaking the Bias

International Women's Day 2022: Breaking the Bias

8 Mar 2022
Mapping cells to understand vascular disease

Mapping cells to understand vascular disease

25 Feb 2022
Study suggests non-classical inhibition of TBK1/IKKε is protective against severe COVID-19 immunopathology in vivo

Study suggests non-classical inhibition of TBK1/IKKε is protective against severe COVID-19 immunopathology in vivo

21 Feb 2022
Smartphone-based COVID-19 detection system

Smartphone-based COVID-19 detection system

17 Feb 2022
Predicting pregnancy health and preeclampsia risk with blood RNA sequencing

Predicting pregnancy health and preeclampsia risk with blood RNA sequencing

27 Jan 2022
The new Omicron subvariant BA.2: what we know so far

The new Omicron subvariant BA.2: what we know so far

26 Jan 2022
Novel gene therapy for diseased muscle fiber repair

Novel gene therapy for diseased muscle fiber repair

24 Jan 2022
‘Moving molecule’ therapy for severe spinal cord injury

‘Moving molecule’ therapy for severe spinal cord injury

7 Dec 2021
New genetic technology for gene expression analysis of cancer cells

New genetic technology for gene expression analysis of cancer cells

3 Dec 2021
Novel anti-inflammatory drug target identified by CRISPR

Novel anti-inflammatory drug target identified by CRISPR

1 Dec 2021

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback